Streetbeat News

Stock Prices

SNAL

Snail (NASDAQ:SNAL) reported Q3 EPS of $(0.12), which was in line with analyst estimates but marked a 200% increase in losses from $(0.04) per share in the same quarter last year. Sales for the quarter were $8.98M, a 42.43% decrease from $15.60M in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 10:06 pm

EFSH

1847 Holdings (AMEX:EFSH) reported a 29.75% increase in sales for Q3, with figures rising to $18.78 million from $14.47 million in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 10:00 pm

OTRK

Ontrak Inc. (OTRK) reported improved financial results for Q3 2023 with an adjusted EPS loss of $(1.61), which is better than the $(2.88) loss per share from the same quarter last year. Sales also increased to $3.71M, up from $2.84M in the same period last year, marking a 30.67% increase.

Portfolio Pulse from vinayak@benzinga.com

November 14, 2023 | 9:59 pm

PEV

Phoenix Motor (NASDAQ:PEV) reported a narrower Q3 loss of $(0.13) per share compared to $(0.20) YoY, but sales declined to $288.00K from $409.00K YoY, indicating mixed financial performance.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 9:59 pm

PEV

Phoenix Motor Inc. (NASDAQ:PEV) has won the bid to acquire the Proterra Transit business from Proterra Inc. for a total cash consideration of $10 million. This acquisition will expand Phoenix's product line to include full-size transit buses, complementing its medium-duty offerings. The deal is subject to U.S. Bankruptcy Court approval, with a hearing scheduled for November 28, 2023. Phoenix will also release its Q3 2023 earnings and host a webcast for investors today.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 9:58 pm

VRAR

Glimpse Group (NASDAQ:VRAR) reported Q1 2024 earnings per share (EPS) of $(0.01), surpassing the $(0.14) estimate, marking a significant improvement from the $(0.40) per share loss in the same quarter last year. However, the company's sales of $3.10M fell short of the expected $3.89M, a 21.42% decrease from the previous year's same-quarter sales of $3.95M.

Portfolio Pulse from vinayak@benzinga.com

November 14, 2023 | 9:57 pm

AGE

AgeX Therapeutics reported a Q3 EPS loss of $(0.14), a significant decrease from the $(0.06) loss per share in the same quarter last year. However, sales saw a substantial increase to $67.00K, up from $9.00K in the same period last year, marking a 644.44% increase.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 9:56 pm

IRIX

Iridex (NASDAQ:IRIX) reported Q3 earnings with an EPS of $-0.11, beating estimates by 8.33% but with a revenue decline of $1.78 million year-over-year. Last quarter's EPS miss led to a 28.25% share price drop the following day. Historical earnings and revenue figures show variability in the company's past performance.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 9:55 pm

NGS

Natural Gas Services Gr (NYSE:NGS) reported Q3 earnings with an EPS of $0.18, surpassing the estimate of $0.07 by 157.14%. Revenue increased by $10.63 million compared to the same period last year. The company had previously beaten EPS estimates in Q2 2023, which led to a 3.96% rise in share price the following day.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 9:55 pm

VERO

Venus Concept (NASDAQ:VERO) reported Q3 earnings with a loss of $(1.64) per share, missing the $(1.51) estimate, but sales of $17.62M exceeded the $17.46M estimate. The EPS miss represents an 8.61% deviation from expectations, while the sales beat is a marginal 0.89% above the estimate. Compared to last year, the loss per share improved by 50.3%, but sales saw an 18.21% decline from $21.54M.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 9:55 pm